Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

BSE’s index option premium market share had earlier shot up to 22.1 per cent in February 2025 from 16.4 per cent in December ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Vishal Mega Mart had as many as 9.13 lakh retail shareholders, or those with authorised share capital of up to ₹2 lakh as of ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

Nuvama slashes BSE's target price, citing reduced volumes from NSE changes and SEBI's derivative rules. Explore the ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

Shares of Zee Entertainment rose on Friday after brokerage house Nuvama maintained a 'buy' rating with a target price of Rs ...

BSE Ltd. shares fell for the fifth consecutive session on March 11, 2025, dropping 16% this month. Nuvama cut its price target, citing concerns over market share due to NSE’s expiry shift. Goldman ...